Loading…

Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex

PRESENTATION of cytoplasmic antigens to class I-restricted cytotoxic T cells implied the existence of a specialized peptide transporter 1–3 (reviewed in ref. 4). For most class I heavy chains, association with peptides of the appropriate length is required for stable assembly with β 2 -microglobulin...

Full description

Saved in:
Bibliographic Details
Published in:Nature (London) 1992-02, Vol.355 (6361), p.641-644
Main Authors: Kelly, Adrian, Powis, Stephen H, Kerr, Lesley-Anne, Mockridge, Ian, Elliott, Timothy, Bastin, Judy, Uchanska-Ziegler, Barbara, Ziegler, Andreas, Trowsdale, John, Townsend, Alain
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:PRESENTATION of cytoplasmic antigens to class I-restricted cytotoxic T cells implied the existence of a specialized peptide transporter 1–3 (reviewed in ref. 4). For most class I heavy chains, association with peptides of the appropriate length is required for stable assembly with β 2 -microglobulin 5–11 . Mutant cells RMA–S (ref. 12) and .174/T2 (refs 13,14) neither assemble stable class I molecules nor present intracellular antigens, and we have suggested that they have lost a function required for the transport of short peptides from the cytosol to the endoplasmic reticulum 5–7 . The genetic defect in .174 has been localized to a large deletion in the class II region of the major histocompatibility complex 6,15,16 , within which two genes ( RING4 and RING11 ) have been identified that code for 'ABC' (ATP-binding cassette) transporters 15,17–21 . We report here that the protein products of these two genes assemble to form a complex. Defects in either protein result in the formation of unstable class I molecules and loss of presentation of intracellular antigens. The molecular defect in a new mutant, BM36.1, is shown to be in the ATP-binding domain of the RING11/PSF2 protein. This is in contrast to the mutant .134 (ref. 15), which lacks the RING4/PSF1 protein.
ISSN:0028-0836
1476-4687
DOI:10.1038/355641a0